메뉴 건너뛰기




Volumn 37, Issue 7-8, 1998, Pages 749-757

Recent developments in palliative cancer care

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; HYDROMORPHONE; MORPHINE; OPIATE AGONIST; PETHIDINE; PSYCHOSTIMULANT AGENT; SUFENTANIL;

EID: 0032432584     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418698430151     Document Type: Article
Times cited : (13)

References (73)
  • 1
    • 0028068659 scopus 로고
    • Symptom prevalence, characteristics, and distress in a cancer population
    • 1. Portenoy RK, Thaler HT, Kornblith AB, et al. Symptom prevalence, characteristics, and distress in a cancer population. Qual Life Res 1994; 3: 183-9.
    • (1994) Qual Life Res , vol.3 , pp. 183-189
    • Portenoy, R.K.1    Thaler, H.T.2    Kornblith, A.B.3
  • 3
    • 0025910622 scopus 로고
    • Correlation of patient and caregiver ratings of cancer pain
    • 3. Grossman SA, Sheidler VR, Sweden K, et al. Correlation of patient and caregiver ratings of cancer pain. J Pain Symp Manage 1991; 6: 53-7.
    • (1991) J Pain Symp Manage , vol.6 , pp. 53-57
    • Grossman, S.A.1    Sheidler, V.R.2    Sweden, K.3
  • 4
    • 0020565258 scopus 로고
    • The validation of visual analogue scales as a ratio scale measurement for chronic and experimental pain
    • 4. Price DD, MacGrath PA, Rafii A, Buckingham B. The validation of visual analogue scales as a ratio scale measurement for chronic and experimental pain. Pain 1983; 17: 45-56.
    • (1983) Pain , vol.17 , pp. 45-56
    • Price, D.D.1    MacGrath, P.A.2    Rafii, A.3    Buckingham, B.4
  • 5
    • 0002197461 scopus 로고
    • Audit methods: The Edmonton symptom assessment system
    • Higginson I, ed. Oxford: Radcliffe Medical Press
    • 5. Bruera E, MacDonald S. Audit methods: the Edmonton Symptom Assessment System. In: Higginson I, ed. Clinical audit in palliative care. Oxford: Radcliffe Medical Press, 1993: 61-77.
    • (1993) Clinical Audit in Palliative Care , pp. 61-77
    • Bruera, E.1    MacDonald, S.2
  • 6
    • 0002354145 scopus 로고
    • Audit methods: Validation and in-patient use
    • Higginson I, ed. Oxford: Radcliffe Medical Press
    • 6. Higginson I. Audit methods: validation and in-patient use. In: Higginson I, ed. Clinical audit in palliative care. Oxford: Radcliffe Medical Press, 1993: 48-54.
    • (1993) Clinical Audit in Palliative Care , pp. 48-54
    • Higginson, I.1
  • 7
    • 0023271255 scopus 로고
    • The memorial pain assessment card. A valid instrument for the evaluation of cancer pain
    • 7. Fishman B, Pasternak S, Wallenstein SL, et al. The Memorial Pain Assessment Card. A valid instrument for the evaluation of cancer pain. Cancer 1987; 60: 1151-8.
    • (1987) Cancer , vol.60 , pp. 1151-1158
    • Fishman, B.1    Pasternak, S.2    Wallenstein, S.L.3
  • 8
    • 0028033880 scopus 로고
    • The memorial symptom assessment scale. An instrument for the evaluation of symptom prevalence, characteristics and distress
    • 8. Portenoy RK, Thaler HT, Kornblith AB, et al. The Memorial Symptom Assessment Scale. An instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 1994; 30A: 1326-36.
    • (1994) Eur J Cancer , vol.30 A , pp. 1326-1336
    • Portenoy, R.K.1    Thaler, H.T.2    Kornblith, A.B.3
  • 9
    • 0018887475 scopus 로고
    • Use of the McGill pain questionnaire in the assessment of cancer pain: Replicability and consistency
    • 9. Graham C, Bond SS, Genkovich MM, et al. Use of the McGill Pain Questionnaire in the assessment of cancer pain: replicability and consistency. Pain 1980; 8: 377-87.
    • (1980) Pain , vol.8 , pp. 377-387
    • Graham, C.1    Bond, S.S.2    Genkovich, M.M.3
  • 10
    • 0020603115 scopus 로고
    • Development of the Wisconsin brief pain questionnaire to assess pain in cancer and other diseases
    • 10. Dant RL, Cleeland CS, Flarery RC. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 1983; 17: 147-210.
    • (1983) Pain , vol.17 , pp. 147-210
    • Dant, R.L.1    Cleeland, C.S.2    Flarery, R.C.3
  • 11
    • 0025639135 scopus 로고
    • Measuring psychological and physical distress in cancer patients: Structure and application of the Rotterdam symptom checklist
    • 11. de Haes JCJM, van Kipperberg FCE, Neijt JP. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer 1990; 62: 1034.
    • (1990) Br J Cancer , vol.62 , pp. 1034
    • De Haes, J.C.J.M.1    Van Kipperberg, F.C.E.2    Neijt, J.P.3
  • 12
    • 0018023522 scopus 로고
    • Development of a symptom distress scale
    • 12. McCorkle R, Young K. Development of a symptom distress scale. Cancer Nurs 1978; 1: 373-8.
    • (1978) Cancer Nurs , vol.1 , pp. 373-378
    • McCorkle, R.1    Young, K.2
  • 13
    • 0027943192 scopus 로고
    • Regular use of a verbal pain scale improves the understanding of oncology inpatient intensity
    • 13. Au E, Loprinzi CL, Dhodapkar M, et al. Regular use of a verbal pain scale improves the understanding of oncology inpatient intensity. J Clin Oncol 1994; 12: 2751-5.
    • (1994) J Clin Oncol , vol.12 , pp. 2751-2755
    • Au, E.1    Loprinzi, C.L.2    Dhodapkar, M.3
  • 14
    • 0025281813 scopus 로고
    • Palliative care in a cancer centre: Results in 1984 versus 1987
    • 14. Bruera E, Macmillan K, Hanson J, et al. Palliative care in a cancer centre: results in 1984 versus 1987. J Pain Symp Manage 1990; 5: 1-5.
    • (1990) J Pain Symp Manage , vol.5 , pp. 1-5
    • Bruera, E.1    Macmillan, K.2    Hanson, J.3
  • 15
    • 0029021038 scopus 로고
    • A prospective multi-center assessment of the Edmonton staging system for cancer pain
    • 15. Bruera E, Schoeller T, Wenk R, et al. A prospective multi-center assessment of the Edmonton Staging System for cancer pain. J Pain Symp Manage 1995; 10: 348-55.
    • (1995) J Pain Symp Manage , vol.10 , pp. 348-355
    • Bruera, E.1    Schoeller, T.2    Wenk, R.3
  • 16
    • 0028857831 scopus 로고
    • Case report: Is this opioid analgesic tolerance?
    • 16. Fainsinger R, Bruera E. Case report: is this opioid analgesic tolerance? J Pain Symp Manage 1995; 10: 573-7.
    • (1995) J Pain Symp Manage , vol.10 , pp. 573-577
    • Fainsinger, R.1    Bruera, E.2
  • 17
    • 0024354949 scopus 로고
    • The Edmonton staging system for cancer pain: Preliminary report
    • 17. Bruera E, Macmillan K, Hanson J, MacDonald RN. The Edmonton staging system for cancer pain: preliminary report. Pain 1989; 37: 203-9.
    • (1989) Pain , vol.37 , pp. 203-209
    • Bruera, E.1    Macmillan, K.2    Hanson, J.3    MacDonald, R.N.4
  • 18
    • 0031038731 scopus 로고    scopus 로고
    • The frequency and clinical course of cognitive impairment in patients with terminal cancer
    • 18. Pereira J, Hanson J, Bruera E. The frequency and clinical course of cognitive impairment in patients with terminal cancer. Cancer 1997; 79: 835-42.
    • (1997) Cancer , vol.79 , pp. 835-842
    • Pereira, J.1    Hanson, J.2    Bruera, E.3
  • 20
    • 0028914128 scopus 로고
    • A critique of instruments and methods to detect, diagnose, and rate delirium
    • 20. Smith MJ, Breitbart WS, Platt MM. A critique of instruments and methods to detect, diagnose, and rate delirium. J Pain Symp Manage 1995; 10: 37-77.
    • (1995) J Pain Symp Manage , vol.10 , pp. 37-77
    • Smith, M.J.1    Breitbart, W.S.2    Platt, M.M.3
  • 21
    • 0020627785 scopus 로고
    • Validation of a short orientation-memory-concentration test of cognitive impairment
    • 21. Katzman R, Brown T, Field P, et al. Validation of a short orientation-memory-concentration test of cognitive impairment. Am J Psychiatry 1983; 140: 734-9.
    • (1983) Am J Psychiatry , vol.140 , pp. 734-739
    • Katzman, R.1    Brown, T.2    Field, P.3
  • 23
    • 0024600152 scopus 로고
    • Prevalence, detection and treatment of alcoholism in hospitalized patients
    • 23. Moore RD, Bone LR, Geller G, et al. Prevalence, detection and treatment of alcoholism in hospitalized patients. J Am Med Assoc 1989; 261: 403-7.
    • (1989) J Am Med Assoc , vol.261 , pp. 403-407
    • Moore, R.D.1    Bone, L.R.2    Geller, G.3
  • 25
    • 0021141362 scopus 로고
    • The Karnofsky performance status scale; an examination of its reliability and validity in a research setting
    • 25. Mor V, Laliberte L, Morris JN, Wiemann M. The Karnofsky Performance Status Scale; an examination of its reliability and validity in a research setting. Cancer 1984; 53: 2002-7.
    • (1984) Cancer , vol.53 , pp. 2002-2007
    • Mor, V.1    Laliberte, L.2    Morris, J.N.3    Wiemann, M.4
  • 26
    • 0027417437 scopus 로고
    • A quality-of-life instrument for use in international clinical trials in oncology
    • 26. Aaronson NK, Ahmedzai S, Bergman B, et al. European Organization for Research and Treatment of Cancer Study Group on Quality of Life. The European Organization for Research and Treatment of Cancer Study Group on Quality of Life-30. A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-76.
    • (1993) J Natl Cancer Inst , vol.85 , pp. 365-376
    • Aaronson, N.K.1    Ahmedzai, S.2    Bergman, B.3
  • 27
    • 0031020055 scopus 로고    scopus 로고
    • The Edmonton functional assessment tool: Preliminary development and evaluation for use in palliative care
    • 27. Kaasa T, Loomis J, Gillis K, et al. The Edmonton Functional Assessment Tool: preliminary development and evaluation for use in palliative care. J Pain Symp Manage 1997; 13: 10-9.
    • (1997) J Pain Symp Manage , vol.13 , pp. 10-19
    • Kaasa, T.1    Loomis, J.2    Gillis, K.3
  • 28
    • 0028558528 scopus 로고
    • The assessment of constipation in terminal cancer patients admitted to a palliative care unit: A retrospective review
    • 28. Bruera E, Suarez-Almazor M, Velasco A, Bertolino M, MacDonald SM, Hanson J. The assessment of constipation in terminal cancer patients admitted to a palliative care unit: a retrospective review. J Pain Symp Manage 1994; 9: 515-9.
    • (1994) J Pain Symp Manage , vol.9 , pp. 515-519
    • Bruera, E.1    Suarez-Almazor, M.2    Velasco, A.3    Bertolino, M.4    MacDonald, S.M.5    Hanson, J.6
  • 30
    • 0027407786 scopus 로고
    • The functional assessment of cancer therapy scale: Development and validation of the general measure
    • 30. Cella DF, Tulsky DJ, Gray G, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 1993; 11: 570-9.
    • (1993) J Clin Oncol , vol.11 , pp. 570-579
    • Cella, D.F.1    Tulsky, D.J.2    Gray, G.3
  • 31
    • 0019841594 scopus 로고
    • Measuring the quality of life of cancer patients; a concise QL-index for use by physicians
    • 31. Spitzer WU, Dobson AJ, Hall J, et al. Measuring the quality of life of cancer patients; a concise QL-index for use by physicians. J Chronic DTS 1981; 34: 585-97.
    • (1981) J Chronic DTS , vol.34 , pp. 585-597
    • Spitzer, W.U.1    Dobson, A.J.2    Hall, J.3
  • 32
    • 0031051008 scopus 로고    scopus 로고
    • Validity of the McGill quality of life questionnaire in the palliative care setting: A multi-centre Canadian study demonstrating the importance of the existential domain
    • 32. Cohen SR, Mount BM, Bruera E, Provost M, Rowe J, Ton K. Validity of the McGill Quality of Life Questionnaire in the palliative care setting: a multi-centre Canadian study demonstrating the importance of the existential domain. Palliat Med 1997; 11: 3-20.
    • (1997) Palliat Med , vol.11 , pp. 3-20
    • Cohen, S.R.1    Mount, B.M.2    Bruera, E.3    Provost, M.4    Rowe, J.5    Ton, K.6
  • 33
    • 0021839202 scopus 로고
    • The treatment of cancer pain
    • 33. Foley K. The treatment of cancer pain. N Engl J Med 1985; 313: 84-95.
    • (1985) N Engl J Med , vol.313 , pp. 84-95
    • Foley, K.1
  • 34
    • 0024324299 scopus 로고
    • Cancer pain epidemiology and symptoms
    • 34. Portenoy RK. Cancer pain epidemiology and symptoms. Cancer 1989; 63: 2298-307.
    • (1989) Cancer , vol.63 , pp. 2298-2307
    • Portenoy, R.K.1
  • 35
    • 0003527864 scopus 로고    scopus 로고
    • Geneva: World Health Organization
    • 35. World Health Organization. Cancer pain relief. 2nd ed. Geneva: World Health Organization, 1996.
    • (1996) Cancer Pain Relief. 2nd Ed.
  • 36
    • 0027461203 scopus 로고
    • Opiophobia and cancer pain in Europe
    • 36. Zenz M, Willweber-Strumpf A. Opiophobia and cancer pain in Europe. Lancet 1993; 341: 1075-6.
    • (1993) Lancet , vol.341 , pp. 1075-1076
    • Zenz, M.1    Willweber-Strumpf, A.2
  • 38
    • 0003377893 scopus 로고    scopus 로고
    • From Florianopolis 1994 to Santo Domingo 1996: A progress report on opioid availability
    • 38. de Lima L, Bruera E, Joranson DE, et al. From Florianopolis 1994 to Santo Domingo 1996: a progress report on opioid availability. Cancer Pain Release 1996; 9: 4-5.
    • (1996) Cancer Pain Release , vol.9 , pp. 4-5
    • De Lima, L.1    Bruera, E.2    Joranson, D.E.3
  • 39
    • 0028969147 scopus 로고
    • Neuropsychiatric syndromes and psychological symptoms in patients with advanced cancer
    • 39. Breitbart W, Bruera E, Chochinov H, Lynch M. Neuropsychiatric syndromes and psychological symptoms in patients with advanced cancer. J Pain Symp Manage 1995; 10: 131-41.
    • (1995) J Pain Symp Manage , vol.10 , pp. 131-141
    • Breitbart, W.1    Bruera, E.2    Chochinov, H.3    Lynch, M.4
  • 40
    • 0031038731 scopus 로고    scopus 로고
    • The frequency and clinical course of cognitive impairment in patients with terminal cancer
    • 40. Pereira J, Hanson J, Bruera E. The frequency and clinical course of cognitive impairment in patients with terminal cancer. Cancer 1997; 79: 835-42.
    • (1997) Cancer , vol.79 , pp. 835-842
    • Pereira, J.1    Hanson, J.2    Bruera, E.3
  • 41
    • 0030579008 scopus 로고    scopus 로고
    • Pharmacologic treatment of cancer pain
    • 41. Levy MH. Pharmacologic treatment of cancer pain. New Engl J Med 1996; 335: 1124-32.
    • (1996) New Engl J Med , vol.335 , pp. 1124-1132
    • Levy, M.H.1
  • 42
    • 0028246011 scopus 로고
    • Management of common opioid side effects during long term therapy of cancer pain
    • 42. Portenoy RK. Management of common opioid side effects during long term therapy of cancer pain. Ann Acad Med 1994; 23: 160-70.
    • (1994) Ann Acad Med , vol.23 , pp. 160-170
    • Portenoy, R.K.1
  • 43
    • 0024818202 scopus 로고
    • Non-cardiogenic pulmonary edema after narcotic treatment for cancer pain
    • 43. Bruera E, Miller MJ. Non-cardiogenic pulmonary edema after narcotic treatment for cancer pain. Pain 1989; 39: 297-300.
    • (1989) Pain , vol.39 , pp. 297-300
    • Bruera, E.1    Miller, M.J.2
  • 44
    • 0027930510 scopus 로고
    • Comparing the subjective, psychomotor and physiological effects of intravenous butorphanol and morphine in healthy volunteers
    • 44. Zacny JP, Lichtor JL, Thapar P, Coalson D, Flemming D, Thompson WK. Comparing the subjective, psychomotor and physiological effects of intravenous butorphanol and morphine in healthy volunteers. J Pharmacol Exp Ther 1994; 270: 579-89.
    • (1994) J Pharmacol Exp Ther , vol.270 , pp. 579-589
    • Zacny, J.P.1    Lichtor, J.L.2    Thapar, P.3    Coalson, D.4    Flemming, D.5    Thompson, W.K.6
  • 45
  • 46
    • 0026624722 scopus 로고
    • Cognitive failure (CF) in patients with terminal cancer: A prospective study
    • 46. Bruera E, Miller L, McCallion J, et al. Cognitive failure (CF) in patients with terminal cancer: a prospective study. J Pain Symp Manage 1992; 7: 192-5.
    • (1992) J Pain Symp Manage , vol.7 , pp. 192-195
    • Bruera, E.1    Miller, L.2    McCallion, J.3
  • 47
    • 0023266542 scopus 로고
    • Antidepressants increase bioavailability of morphine in cancer patients
    • 47. Ventafridda V, Ripamonti C, De Conno F, et al. Antidepressants increase bioavailability of morphine in cancer patients. Lancet 1987; 1: 1204.
    • (1987) Lancet , vol.1 , pp. 1204
    • Ventafridda, V.1    Ripamonti, C.2    De Conno, F.3
  • 48
    • 0025034181 scopus 로고
    • Oral morphine in cancer pain: Influences on morphine and metabolite concentration
    • 48. McQuay HJ, Carroll D, Faura CC, et al. Oral morphine in cancer pain: influences on morphine and metabolite concentration. Clin Pharmacol Ther 1990; 48: 236-44.
    • (1990) Clin Pharmacol Ther , vol.48 , pp. 236-244
    • McQuay, H.J.1    Carroll, D.2    Faura, C.C.3
  • 49
    • 0026518201 scopus 로고
    • Organic hallucinosis in patients receiving high doses of opiates for cancer pain
    • 49. Bruera E, Schoeller T, Montejo G. Organic hallucinosis in patients receiving high doses of opiates for cancer pain. Pain 1992; 48: 397-9.
    • (1992) Pain , vol.48 , pp. 397-399
    • Bruera, E.1    Schoeller, T.2    Montejo, G.3
  • 50
    • 0026519251 scopus 로고
    • Clonazepam treatment of myoclonic contractions associated with high-dose opioids: Case report
    • 50. Eisele JH, Grigsby EJ, Dea G. Clonazepam treatment of myoclonic contractions associated with high-dose opioids: case report. Pain 1992; 49: 231-2.
    • (1992) Pain , vol.49 , pp. 231-232
    • Eisele, J.H.1    Grigsby, E.J.2    Dea, G.3
  • 51
    • 0027508664 scopus 로고
    • Putative role of hydromorphone metabolites in myoclonus
    • 51. Babul N, Darke AC. Putative role of hydromorphone metabolites in myoclonus. Pain 1993; 52: 123.
    • (1993) Pain , vol.52 , pp. 123
    • Babul, N.1    Darke, A.C.2
  • 52
    • 0027311289 scopus 로고
    • Opioid hyperexcitability: The application of alternate opioid therapy
    • 52. MacDonald N, Der L, Allan S, et al. Opioid hyperexcitability: the application of alternate opioid therapy. Pain 1993; 53: 353-5.
    • (1993) Pain , vol.53 , pp. 353-355
    • MacDonald, N.1    Der, L.2    Allan, S.3
  • 53
    • 0017653599 scopus 로고
    • Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure or cancer
    • 53. Szeto HH, Inturrisi CE, Houde R, et al. Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure or cancer. Ann Intern Med 1977; 86: 738-41.
    • (1977) Ann Intern Med , vol.86 , pp. 738-741
    • Szeto, H.H.1    Inturrisi, C.E.2    Houde, R.3
  • 54
    • 0020675827 scopus 로고
    • Central nervous system excitatory effects of meperidine in cancer patients
    • 54. Kaiko RF, Foley KM, Grabinski PY, et al. Central nervous system excitatory effects of meperidine in cancer patients. Ann Neurol 1983; 13: 180-5.
    • (1983) Ann Neurol , vol.13 , pp. 180-185
    • Kaiko, R.F.1    Foley, K.M.2    Grabinski, P.Y.3
  • 55
    • 0023549913 scopus 로고
    • Myoclonus following sufentanil without EEG seizure activity
    • 55. Bowdle TA. Myoclonus following sufentanil without EEG seizure activity. Anesthesiology 1987; 67: 593-5.
    • (1987) Anesthesiology , vol.67 , pp. 593-595
    • Bowdle, T.A.1
  • 57
    • 0027527448 scopus 로고
    • Hyperalgesia and myoclonus in terminal cancer patients treated with continuous intravenous morphine
    • 57. Sjogren P, Jonsson T, Jensen N-H, et al. Hyperalgesia and myoclonus in terminal cancer patients treated with continuous intravenous morphine. Pain 1993; 55: 93-7.
    • (1993) Pain , vol.55 , pp. 93-97
    • Sjogren, P.1    Jonsson, T.2    Jensen, N.-H.3
  • 58
    • 0027944339 scopus 로고
    • Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonists
    • 58. Sjogren P, Jensen N-H, Jensen T-S. Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonists. Pain 1994; 59: 313-6.
    • (1994) Pain , vol.59 , pp. 313-316
    • Sjogren, P.1    Jensen, N.-H.2    Jensen, T.-S.3
  • 60
    • 0019524261 scopus 로고
    • Intrathecal high dose morphine produces hyperalgesia in the rat
    • 60. Woolf CJ. Intrathecal high dose morphine produces hyperalgesia in the rat. Brain Res 1981; 209: 491-5.
    • (1981) Brain Res , vol.209 , pp. 491-495
    • Woolf, C.J.1
  • 61
    • 0022558928 scopus 로고
    • High dose of spinal morphine produces a nonopiate receptor-mediated hyperesthesia: Clinical and theoretic implications
    • 61. Yaksh TL, Harty GJ, Onofrio BM. High dose of spinal morphine produces a nonopiate receptor-mediated hyperesthesia: clinical and theoretic implications. Anesthesiology 1986; 64: 590-7.
    • (1986) Anesthesiology , vol.64 , pp. 590-597
    • Yaksh, T.L.1    Harty, G.J.2    Onofrio, B.M.3
  • 62
    • 0026501373 scopus 로고
    • Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat
    • 62. Gong QL, Hedner J, Björkman R, Hedner T. Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat. Pain 1992; 48: 249-55.
    • (1992) Pain , vol.48 , pp. 249-255
    • Gong, Q.L.1    Hedner, J.2    Björkman, R.3    Hedner, T.4
  • 63
    • 0029162234 scopus 로고
    • Mechanisms of hyperalgesia and morphine tolerance: A current view of their possible interactions
    • 63. Mao J, Price DD, Mayer DJ. Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 1995; 62: 259-74.
    • (1995) Pain , vol.62 , pp. 259-274
    • Mao, J.1    Price, D.D.2    Mayer, D.J.3
  • 64
    • 0021965084 scopus 로고
    • Intrathecal morphine induces myoclonic seizures in the rat
    • 64. Shohami E, Evron S. Intrathecal morphine induces myoclonic seizures in the rat. Acta Pharmacol Toxicol 1985; 56: 50-4.
    • (1985) Acta Pharmacol Toxicol , vol.56 , pp. 50-54
    • Shohami, E.1    Evron, S.2
  • 65
    • 0027275184 scopus 로고
    • Spatial patterns of increased spinal cord membrane-bound protein kinase C and their relation to increases in C-2-deoxyglucose metabolic activity in rats with painful peripheral mononeuropathy
    • 65. Mao J, Mayer DJ, Hayes RL, Price DD. Spatial patterns of increased spinal cord membrane-bound protein kinase C and their relation to increases in C-2-deoxyglucose metabolic activity in rats with painful peripheral mononeuropathy. J Neurophysiol 1993; 70: 470-81.
    • (1993) J Neurophysiol , vol.70 , pp. 470-481
    • Mao, J.1    Mayer, D.J.2    Hayes, R.L.3    Price, D.D.4
  • 66
    • 0028905662 scopus 로고
    • Ketobemidone, methadone and pethidine are non-competitive N-methyl-D-asparate (NMDA) antagonists in the rat cortex and spinal cord
    • 66. Ebert B, Andersen S, Krogsgaard-Larsen P. Ketobemidone, methadone and pethidine are non-competitive N-methyl-D-asparate (NMDA) antagonists in the rat cortex and spinal cord. Neurosci Lett 1995; 187: 165-8.
    • (1995) Neurosci Lett , vol.187 , pp. 165-168
    • Ebert, B.1    Andersen, S.2    Krogsgaard-Larsen, P.3
  • 67
    • 0029758390 scopus 로고    scopus 로고
    • Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone and morphine
    • 67. Bruera E, Pereira J, Watanabe S, Belzile M, Kuehn N, Hanson J. Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone and morphine. Cancer 1996; 78: 852-7.
    • (1996) Cancer , vol.78 , pp. 852-857
    • Bruera, E.1    Pereira, J.2    Watanabe, S.3    Belzile, M.4    Kuehn, N.5    Hanson, J.6
  • 68
    • 0021816535 scopus 로고
    • Continuons infusion of spinally administered narcotics for the relief of pain due to malignant disorders
    • 68. Krames ES, Gershow Y, Glassberg A. Continuons infusion of spinally administered narcotics for the relief of pain due to malignant disorders. Cancer 1985; 56: 696-702.
    • (1985) Cancer , vol.56 , pp. 696-702
    • Krames, E.S.1    Gershow, Y.2    Glassberg, A.3
  • 69
    • 0028567815 scopus 로고
    • Organic brain syndromes and opioid administration for cancer pain
    • 69. Caraceni A, Martini C, De Conno F, et al. Organic brain syndromes and opioid administration for cancer pain. J Pain Symp Manage 1994; 9: 527-33.
    • (1994) J Pain Symp Manage , vol.9 , pp. 527-533
    • Caraceni, A.1    Martini, C.2    De Conno, F.3
  • 70
    • 0026750389 scopus 로고
    • Circadian distribution of extra doses of narcotic analgesics in patients with cancer pain. A preliminary report
    • 70. Bruera E, Macmillan K, Kuehn N, Miller MJ. Circadian distribution of extra doses of narcotic analgesics in patients with cancer pain. A preliminary report. Pain 1992; 49: 311-4.
    • (1992) Pain , vol.49 , pp. 311-314
    • Bruera, E.1    Macmillan, K.2    Kuehn, N.3    Miller, M.J.4
  • 71
    • 0029071983 scopus 로고
    • Clinical efficacy and safety of a novel controlled release morphine suppository and subcutaneous morphine in cancer pain: A randomized evaluation
    • 71. Bruera E, Fainsinger R, Spachynski K, Babul N, Harsanyi Z, Darke AC. Clinical efficacy and safety of a novel controlled release morphine suppository and subcutaneous morphine in cancer pain: a randomized evaluation. J Clin Oncol 1995; 13: 1520-7.
    • (1995) J Clin Oncol , vol.13 , pp. 1520-1527
    • Bruera, E.1    Fainsinger, R.2    Spachynski, K.3    Babul, N.4    Harsanyi, Z.5    Darke, A.C.6
  • 72
    • 0028021318 scopus 로고
    • The use of hypodermoclysis for rehydration in terminally ill cancer patients
    • 72. Fainsinger RL, MacEachern T, Miller MJ, et al. The use of hypodermoclysis for rehydration in terminally ill cancer patients. J Pain Symp Manage 1994; 9: 298-302.
    • (1994) J Pain Symp Manage , vol.9 , pp. 298-302
    • Fainsinger, R.L.1    MacEachern, T.2    Miller, M.J.3
  • 73
    • 0027935835 scopus 로고
    • Psychostimulants as adjuvant analgesics
    • 73. Bruera E, Watanabe S. Psychostimulants as adjuvant analgesics. J Pain Symp Manage 1994; 9: 412-5.
    • (1994) J Pain Symp Manage , vol.9 , pp. 412-415
    • Bruera, E.1    Watanabe, S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.